Cardiokol Ltd.
Digital Health — Stage: R&D. Est: 2017. Tags: Artificial Intelligence, Biochips, Digital Health, Healthtech, Life Sciences, MedTech, Monitoring, RetailTech, Screening, Telehealth. Cardiokol develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations. The company utilizes proprietary technology that is implemented in speech platforms, like landlines, smart phones, smart-speakers and voice assistants. Cardiokol offers low-cost, long-term and age-friendly monitoring solutions, applicable for mass at-risk populations of older adults (65+).. Web: https://cardiokol.com